Patel Provides Perspective on Immunotherapy Developments in NSCLC – OncLive
OncLive |
Patel Provides Perspective on Immunotherapy Developments in NSCLC
OncLive Immunotherapy's introduction into the field of non–small cell lung cancer has revolutionized the treatment landscape, most recently following the phase III results of clinical trials such as PACIFIC and KEYNOTE-189, said Sandip P. Patel, MD. Yet … |
